Literature DB >> 17682629

Buprenorphine maintenance: a new treatment for opioid dependence.

Gregory B Collins1, Mark S McAllister.   

Abstract

Buprenorphine (Subutex) is a safe and effective treatment for opioid dependence, and has very low potential for abuse, especially when it is combined with naloxone (Narcan) in a single sublingual tablet (Suboxone). New regulations allow physicians who are certified in buprenorphine therapy to offer it in their offices, a development that can substantially increase patient access to treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17682629     DOI: 10.3949/ccjm.74.7.514

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  7 in total

1.  A urinalysis-based comparative study of treatment adherence on buprenorphine and buprenorphine/naloxone combination used as opioid substitution therapy.

Authors:  Yatan Pal Singh Balhara; Raka Jain
Journal:  Innov Clin Neurosci       Date:  2012-07

Review 2.  Buprenorphine-naloxone therapy in pain management.

Authors:  Kelly Yan Chen; Lucy Chen; Jianren Mao
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

3.  Medications for Opioid Use Disorder: A Guide for Physicians.

Authors:  Naazia Azhar; Ravikumar Chockalingam; Asad Azhar
Journal:  Mo Med       Date:  2020 Jan-Feb

Review 4.  Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Authors:  Michael A Yokell; Nickolas D Zaller; Traci C Green; Josiah D Rich
Journal:  Curr Drug Abuse Rev       Date:  2011-03

5.  Chemical and enzyme-assisted syntheses of norbuprenorphine-3-β-D-glucuronide.

Authors:  Jinda Fan; Sarah M Brown; Zhude Tu; Evan D Kharasch
Journal:  Bioconjug Chem       Date:  2011-03-24       Impact factor: 4.774

6.  Chronic in utero buprenorphine exposure causes prolonged respiratory effects in the guinea pig neonate.

Authors:  Michael Wallisch; Chinmayee V Subban; Rosemary T Nettleton; George D Olsen
Journal:  Neurotoxicol Teratol       Date:  2009-12-31       Impact factor: 3.763

7.  A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance.

Authors:  Yatan Pal Singh Balhara; Raka Jain
Journal:  J Pharmacol Pharmacother       Date:  2012-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.